FDA approves gadofosveset trisodium (Vasovist) as first contrast agent for magnetic resonance angiography (MRA)
FDA press release about the approval of Vasovist (gadofosveset trisodium), the first contrast agent for magnetic resonance angiography. Dated December 24, 2008. FDA Approves First Imaging Agent to Enhance Scans of Blood Flow Helps detect possible blood vessel problems The U.S. Food and Drug Administration today approved Vasovist Injection (gadofosveset trisodium), the first contrast imaging agent for […]